In contrast, AML cells expressing the RUNX1::ETO fusion protein do not execute a HOXA9/MEIS1 transcriptional programme and are not affected by Menin inhibitors, strongly suggesting a correlation between HOXA/MEIS1 expression and MLL–Menin dependence. The gene discussed is KMT2A; the disease is acute myeloid leukemia.